Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 36)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10New Constructs, LLCN/ASNMX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for SNMX: the economy's impact on SNMX's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
8-Feb-10ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for SNMX13$25  View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
8-Feb-10PriceTarget Research, Inc.N/ASenomyx has a current Overall Rating of C (Neutral).7$25  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Food and Beverages (North America)71$169  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Food and Beverages (United States)70$169  View Abstract
7-Feb-10Pechala's ReportsFrantisek PechalaSENOMYX INC (SNMX=US) 12-months forecast1$15  View Abstract
7-Feb-10PriceTarget Research, Inc.N/AHealth Serv & Equipment Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 25 new Laggards.65$20  View Abstract
6-Feb-10Standard & Poor's STARS ReportN/ASenomyx Inc8$35  View Abstract
Next 20
Brokerage Reports (Showing 1 to 4 of 4)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
1-Feb-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary18$50  View Abstract
29-Jan-10Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew Vaino PhDFirmenich To Develop S6973­-A Sweet Result For Senomyx4$104 Stars 4 Stars View Abstract
4-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary13$50  View Abstract
4-Jan-10Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew Vaino PhDA 2010 Catalyst Calendar Of Roth Biotech Coverage8$25 4 Stars View Abstract
Independent Reports (Showing 1 to 10 of 32)
Release
Date [down]		 Contributor Author Title Pages Price More Info
9-Feb-10New Constructs, LLCN/ASNMX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for SNMX: the economy's impact on SNMX's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
8-Feb-10ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for SNMX13$25View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
8-Feb-10PriceTarget Research, Inc.N/ASenomyx has a current Overall Rating of C (Neutral).7$25View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Food and Beverages (North America)71$169View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Food and Beverages (United States)70$169View Abstract
7-Feb-10Pechala's ReportsFrantisek PechalaSENOMYX INC (SNMX=US) 12-months forecast1$15View Abstract
7-Feb-10PriceTarget Research, Inc.N/AHealth Serv & Equipment Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 25 new Laggards.65$20View Abstract
6-Feb-10Standard & Poor's STARS ReportN/ASenomyx Inc8$35View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.